Breaking News - Candlesense

CISCO REPORTS FOURTH QUARTER AND FISCAL YEAR 2025 EARNINGS

SAN JOSE, Calif., Aug. 13, 2025 /PRNewswire/ -- News Summary: Strong topline performance at the high end of our guidance ranges: Q4 revenue of $14.7 billion, up 8% year over year FY 2025 revenue of...

What is the outlook for Cisco’s key growth areas (e.g., security, AI‑enabled networking, hybrid cloud) and how are they reflected in the guidance? How does Cisco’s earnings growth compare with the broader tech sector’s performance this quarter? What guidance revisions, if any, were provided for Q1 2026, and how might they affect the stock’s near‑term trajectory?

Symbol: CSCO

Earnings

25 days ago

Read more prnewswire

Helen of Troy Limited Announces G. Scott Uzzell Appointed to Become Chief Executive Officer

EL PASO, Texas--(BUSINESS WIRE)--Helen of Troy Limited (NASDAQ: HELE), designer, developer, and worldwide marketer of branded consumer home, outdoor, beauty, and wellness products, today announced ...

Is there any indication that the new CEO will pursue M&A activity, divestitures, or other capital‑allocation strategies? Will the appointment influence analyst sentiment or trigger any upgrades/downgrades from rating agencies? Could the CEO change trigger any re‑valuation of the company’s earnings forecasts or guidance?

Symbol: HELE

Management

25 days ago

Red Robin Gourmet Burgers, Inc. Reports Results for the Fiscal Second Quarter Ended July 13, 2025

ENGLEWOOD, Colo., Aug. 13, 2025 /PRNewswire/ -- Red Robin Gourmet Burgers, Inc. (NASDAQ: RRGB) ("Red Robin" or the "Company"), a full-service restaurant chain serving an innovative selection of hig...

How does the current valuation (e.g., P/E, EV/EBITDA) compare to historical averages and sector peers? Are there any macroeconomic or consumer trends highlighted that could affect future performance? Did the company mention any operational initiatives or menu innovations that could drive future growth?

Symbol: RRGB

Earnings

25 days ago

Read more prnewswire

Accuray Reports Fourth Quarter and Fiscal 2025 Financial Results

Strong Service Growth; Debt Refinancing Complete; Company Issues FY26 Guidance MADISON, Wis., Aug. 13, 2025 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported financial results for ...

How might the recent earnings and guidance influence the stock price and trading volume in the near term? What is the outlook for capital expenditures and R&D spending in FY26, and how might that affect profitability? Are there any upcoming product launches, regulatory approvals, or pipeline developments that could impact future results?

Symbol: ARAY

Earnings

25 days ago

Read more prnewswire

Resideo Announces Completion of Transaction with Honeywell To Accelerate Payment of All Potential Monetary Obligations Under Indemnification and Reimbursement Agreement

SCOTTSDALE, Ariz., Aug. 13, 2025 /PRNewswire/ -- Resideo Technologies, Inc. (NYSE: REZI), a leading global manufacturer, developer, and distributor of technology-driven sensing and controls product...

What are analysts' expectations regarding the impact on earnings per share (EPS) for the upcoming quarters? How does this transaction compare with similar indemnification settlements in the industry? Are there any contingent liabilities or future payments that could still affect the company's financials?

Symbol: REZI

Mergers

25 days ago

Read more prnewswire

Inhibrx Reports Second Quarter 2025 Financial Results

SAN DIEGO, Aug. 13, 2025 /PRNewswire/ -- Inhibrx Biosciences, Inc. (Nasdaq: INBX) ("Inhibrx" or the "Company") today reported financial results for the second quarter of 2025. Following the complet...

What is the analyst consensus and target price revision, if any, following this earnings release? Are there any risks or uncertainties disclosed in the filing that could affect future performance (e.g., litigation, regulatory delays)? What is the outlook for the remaining INBRX product candidates and their potential impact on revenue growth?

Symbol: INBX

Earnings

25 days ago

Read more prnewswire

Jianpu Technology Inc. Announces Ex-dividend Date for Recently Announced Cash Dividend

BEIJING, Aug. 13, 2025 /PRNewswire/ -- Jianpu Technology Inc. ("Jianpu," or the "Company") (OTCQB: AIJTY), a leading open financial technology platform in China, today announced that FINRA has set ...

Will there be any insider buying or selling around the announcement that could signal confidence or concerns? Does the dividend impact the company's credit rating or debt covenants? Are there any regulatory or compliance considerations tied to the FINRA‑set ex‑dividend date?

Symbol: AIJTY

Dividends

25 days ago

Read more prnewswire

SurgePays Accelerates Growth Across All Business Verticals; Reports Q2 2025 Results and Issues Revenue Guidance of $75M to $90M in 2025 and $225M to $240M in 2026

BARTLETT, Tenn., Aug. 13, 2025 /PRNewswire/ -- SurgePays, Inc. (Nasdaq: SURG) ("SurgePays" or the "Company"), a wireless and point-of-sale technology company, today announced its financial results ...

How might the revised guidance influence short‑term trading activity and price volatility of SURG stock? What macro‑economic or regulatory risks could affect the company's forward‑looking guidance? Will the company need additional equity or debt financing to meet its growth targets, and what dilution or leverage risks does that pose?

Symbol: SURG

Earnings

25 days ago

Read more prnewswire

Epsilon Announces Second Quarter 2025 Results and Transformative Acquisitions in the Powder River Basin

HOUSTON, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Epsilon Energy Ltd. (“Epsilon” or the “Company”) (NASDAQ: EPSN) today announced it has entered into definitive agreements to acquire two entities (Peak ...

How might the market react to this news in the short term, and what price targets are analysts adjusting in response? What are the potential risks associated with the integration of the Peak assets, such as operational, environmental, or market risks? Will there be any impact on dividends, share buybacks, or other shareholder return programs as a result of the deal?

Symbol: EPSN

Mergers

25 days ago

Kezar Life Sciences Reports Second Quarter 2025 Financial Results and Provides Business Update

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company developing novel small molecule therapeutics to treat unmet needs in im...

What impact could potential collaborations or licensing deals have on the company's growth trajectory? Has the company provided guidance for future quarters, and how does that align with analyst expectations? What are the potential risks or uncertainties associated with the clinical trial outcomes for zetomipzomib?

Symbol: KZR

Earnings

25 days ago